Physician profile
Maria Sequeira
NPI 1346537362
$717.19
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25.45 · 2021: $55.65 · 2022: $214 · 2023: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $146.67 | 2022-2023 | Mounjaro |
| Novo Nordisk INC | $113.66 | 2022-2023 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $72.86 | 2022-2023 | |
| Abbvie INC. | $67.95 | 2022-2023 | Vraylar |
| Exact Sciences Corporation | $65.89 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.93 | 2021-2023 | |
| Glaxosmithkline, LLC. | $61.52 | 2022-2023 | Arexvy, Shingrix |
| Kowa Pharmaceuticals America, INC. | $29.17 | 2022 | |
| Amarin Pharma, INC. | $27.07 | 2021-2022 | |
| Hologic Sales and Service, LLC | $25.45 | 2020 | |
| Amgen INC. | $16.67 | 2023 | Otezla, Repatha |
| Scilex Pharmaceuticals INC. | $13.85 | 2021 | |
| Merck Sharp & Dohme LLC | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Sequeira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.